高级搜索
原发性肝癌的CT 血供分型与VEGF相关性[J]. 肿瘤防治研究, 2007, 34(06): 446-448. DOI: 10.3971/j.issn.1000-8578.1397
引用本文: 原发性肝癌的CT 血供分型与VEGF相关性[J]. 肿瘤防治研究, 2007, 34(06): 446-448. DOI: 10.3971/j.issn.1000-8578.1397
MSCT Feature of Tumor Blood Supply Type in Patients with Hepatocellular Carcinoma :Correlation with Serum Vascular Endothel ial Growth Factor( VEGF)[J]. Cancer Research on Prevention and Treatment, 2007, 34(06): 446-448. DOI: 10.3971/j.issn.1000-8578.1397
Citation: MSCT Feature of Tumor Blood Supply Type in Patients with Hepatocellular Carcinoma :Correlation with Serum Vascular Endothel ial Growth Factor( VEGF)[J]. Cancer Research on Prevention and Treatment, 2007, 34(06): 446-448. DOI: 10.3971/j.issn.1000-8578.1397

原发性肝癌的CT 血供分型与VEGF相关性

MSCT Feature of Tumor Blood Supply Type in Patients with Hepatocellular Carcinoma :Correlation with Serum Vascular Endothel ial Growth Factor( VEGF)

  • 摘要: 目的 检测肝细胞癌(Hepatocellular carcinoma,HCC)患者血清血管内皮细胞生长因子(vascu-lar endothelial growth factor,VEGF)水平与HCC血供分型的关系。方法 根据多层螺旋CT(multislice helical computed tomography,MSCT)增强扫描时病灶的强化特点分为肝动脉、肝动脉加门静脉、少血供等不同血供类型HCC患者60例;采用酶联免疫吸附(ELISA)法检测20例健康人和60例HCC患者血清中的VEGF水平,并将HCC血供类型与血管内皮细胞生长因子(VEGF)水平的相关性作统计学分析。结果 20例肝动脉血供HCC患者血清中VEGF含量及20例门静脉与肝动脉双重血供HCC患者VEGF水平明显高于少血供和健康人群(P〈0.01);20例少血供HCC患者VEGF水平与健康人群无明显差异(P〉0.05)。结论 HCC患者的CT不同血供类型与血清VEGF水平有关,可为HCC介入治疗方案的制定提供帮助。

     

    Abstract: Objective  To study the correlation between the multislice helical CT(MSCT) feature of tumor blood supply type in patients with hepatocellular carcinoma ( HCC) and the serum level of vascular endothelial growth factor (VEGF) . Methods  According to the cont rast-enhanced characteristic of lesion on MSCT, the tumor blood supply in 60 patients with HCC were classified into different types such as arterial blood supply, portal blood supply, arteroportal blood supply, and poorly blood supply. Enzyme linked immunosorbent assay ( ELISA) was used to test the serum levels of VEGF collected from 20 healthy individuals and 60 patient s with HCC respectively. At last, the CT features of tumor blood supply type were performed statistical analysis with the serum levels of VEGF. Results  The serum levels of VEGF in 20 patients with arterial blood supply type and 20 patients with arteroportal blood supply were significantly higher than that in 20 healthy individuals and 20 patients with portal blood supply or poorly blood supply type ( P < 0. 01) . There was no statistical significance of serum VEGF levels between 20 patients with portal blood supply or poorly blood supply type and 20 healthy individuals ( P > 0. 05) . Conclusion  The pattern of tumor blood supply for HCC on MSCT is correlative with the serum level of VEGF, and it is of great value in the interventional therapy for HCC.

     

/

返回文章
返回